<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pita-Grisanti V</submitter><funding>Division of Diabetes, Endocrinology, and Metabolic Diseases</funding><funding>U.S. Department of Veterans Affairs</funding><pagination>316-326</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12823344</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>75(2)</volume><pubmed_abstract>&lt;h4>Article highlights&lt;/h4>Mammalian target of rapamycin complex 1 (mTORC1) signaling is essential to β-cell mass, function, and adaptive immunity; however, its specific downstream mediators in type 1 diabetes (T1D) remain poorly defined. We investigated eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2), a major translational regulator downstream of mTORC1, by using global 4E-BP2-knockout mice on the NOD background. Loss of 4E-BP2 protected male NOD mice from T1D through preservation of β-cell mass and function, coupled with attenuation of autoimmune responses. These findings identify 4E-BP2 as a novel immunometabolic node, highlighting its potential as a therapeutic target for T1D prevention and treatment.</pubmed_abstract><journal>Diabetes</journal><pubmed_title>Protection Against Type 1 Diabetes Development in Mice With 4E-BP2 Deletion.</pubmed_title><pmcid>PMC12823344</pmcid><funding_grant_id>R01DK133183</funding_grant_id><funding_grant_id>R01DK132103</funding_grant_id><funding_grant_id>T01BX002728</funding_grant_id><funding_grant_id>R01DK138471</funding_grant_id><pubmed_authors>Pita-Grisanti V</pubmed_authors><pubmed_authors>Arenas N</pubmed_authors><pubmed_authors>Bayer A</pubmed_authors><pubmed_authors>Jaramillo C</pubmed_authors><pubmed_authors>Bernal-Mizrachi E</pubmed_authors><pubmed_authors>Louzada RA</pubmed_authors><pubmed_authors>Blandino-Rosano M</pubmed_authors><pubmed_authors>Pecanha FLM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Protection Against Type 1 Diabetes Development in Mice With 4E-BP2 Deletion.</name><description>&lt;h4>Article highlights&lt;/h4>Mammalian target of rapamycin complex 1 (mTORC1) signaling is essential to β-cell mass, function, and adaptive immunity; however, its specific downstream mediators in type 1 diabetes (T1D) remain poorly defined. We investigated eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2), a major translational regulator downstream of mTORC1, by using global 4E-BP2-knockout mice on the NOD background. Loss of 4E-BP2 protected male NOD mice from T1D through preservation of β-cell mass and function, coupled with attenuation of autoimmune responses. These findings identify 4E-BP2 as a novel immunometabolic node, highlighting its potential as a therapeutic target for T1D prevention and treatment.</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-06T18:08:28.434Z</modification><creation>2026-06-04T03:10:31.174Z</creation></dates><accession>S-EPMC12823344</accession><cross_references><pubmed>41236207</pubmed><doi>10.2337/db25-0348</doi></cross_references></HashMap>